Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Copaiba is a natural oleoresin obtained from the trunk of several South American trees of the genus Copaifera. The resin is traditionally tapped and can be used in its raw form (copaiba balsam/oleoresin) or distilled to produce copaiba essential oil. The main bioactive components are sesquiterpenes such as beta-caryophyllene and beta-bisabolene, along with diterpenic acids like copalic acid and kaurenoic acid[6][4]. These compounds confer anti-inflammatory, analgesic (pain-relieving), antimicrobial, antiseptic, wound-healing, expectorant, diuretic, antirheumatic and antioxidant properties[2][3][4][5]. Copaiba has been used in traditional medicine for centuries for conditions including arthritis (osteoarthritis/rheumatoid arthritis), skin diseases (psoriasis/eczema), wound healing, respiratory tract infections (coughs/bronchitis), urinary tract infections/cystitis/kidney infection, gastrointestinal ulcers/gastritis/H. pylori infection and as an adjunct in oral health[1][2][3][7]. Its mechanism of action is primarily attributed to modulation of inflammatory pathways—especially via activation of cannabinoid CB2 receptors by beta-caryophyllene—and broad-spectrum antimicrobial effects[5]. While widely used as a dietary supplement or topical agent in creams/oils/shampoos/lotions/capsules globally—including Brazil’s herbal medicine system—robust clinical evidence supporting many uses remains limited.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on copaiba.